Isobel Firth
Publications and Insights
- Publication: Capturing the Broader Value of Antibiotics
- Publication: A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance
- Publication: Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism
- Insight: How Does Pharmaceutical Spending Drive Innovation in Europe?
- Publication: Supporting the Era of Green Pharmaceuticals in the UK
- Insight: Does the New CBO Report Change Anything?
- Insight: Due to the Unprecedented Nature of H.R. 3, the CBO Analysis is Unreliable and Can’t Inform Policymaking
- Insight: The CBO Doesn’t Understand Investors
- Insight: H.R. 3 is the Wrong Policy for the Wrong Problem
- Insight: Does Government Funding Increase Public Sector Development of New Medicines?
- Publication: Exploring the Financial Sustainability of Gene Therapies